Standard
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer : a cohort study. / Allin, Kristine H; Nordestgaard, Børge G; Flyger, Henrik; Bojesen, Stig E.
In:
Breast Cancer Research (Online Edition), Vol. 13, No. 3, 2011, p. R55.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Allin, KH
, Nordestgaard, BG, Flyger, H
& Bojesen, SE 2011, '
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study',
Breast Cancer Research (Online Edition), vol. 13, no. 3, pp. R55.
https://doi.org/10.1186/bcr2891APA
Allin, K. H.
, Nordestgaard, B. G., Flyger, H.
, & Bojesen, S. E. (2011).
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.
Breast Cancer Research (Online Edition),
13(3), R55.
https://doi.org/10.1186/bcr2891Vancouver
Allin KH
, Nordestgaard BG, Flyger H
, Bojesen SE.
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.
Breast Cancer Research (Online Edition). 2011;13(3):R55.
https://doi.org/10.1186/bcr2891Author
Allin, Kristine H ; Nordestgaard, Børge G ; Flyger, Henrik ; Bojesen, Stig E. / Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer : a cohort study. In: Breast Cancer Research (Online Edition). 2011 ; Vol. 13, No. 3. pp. R55.
Bibtex
@article{78a4cc672c884ed8b521be322dfe56f4,
title = "Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study",
abstract = "We examined whether plasma C-reactive protein (CRP) levels at the time of diagnosis of breast cancer are associated with overall survival, disease-free survival, death from breast cancer, and recurrence of breast cancer.",
author = "Allin, {Kristine H} and Nordestgaard, {B{\o}rge G} and Henrik Flyger and Bojesen, {Stig E}",
year = "2011",
doi = "http://dx.doi.org/10.1186/bcr2891",
language = "English",
volume = "13",
pages = "R55",
journal = "Breast Cancer Research",
issn = "1465-5411",
publisher = "BioMed Central Ltd.",
number = "3",
}
RIS
TY - JOUR
T1 - Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer
T2 - a cohort study
AU - Allin, Kristine H
AU - Nordestgaard, Børge G
AU - Flyger, Henrik
AU - Bojesen, Stig E
PY - 2011
Y1 - 2011
N2 - We examined whether plasma C-reactive protein (CRP) levels at the time of diagnosis of breast cancer are associated with overall survival, disease-free survival, death from breast cancer, and recurrence of breast cancer.
AB - We examined whether plasma C-reactive protein (CRP) levels at the time of diagnosis of breast cancer are associated with overall survival, disease-free survival, death from breast cancer, and recurrence of breast cancer.
U2 - http://dx.doi.org/10.1186/bcr2891
DO - http://dx.doi.org/10.1186/bcr2891
M3 - Journal article
VL - 13
SP - R55
JO - Breast Cancer Research
JF - Breast Cancer Research
SN - 1465-5411
IS - 3
ER -
